放射治疗同步周剂量紫杉醇治疗老年性非小细胞肺癌的临床研究
详细信息    查看官网全文
摘要
目的:分析放射治疗同步周剂量紫杉醇治疗局部晚期非小细胞肺癌的临床效果。方法:选择2012年5月-2014年5月80例局部晚期非小细胞肺癌患者纳入本次研究对象,根据时间顺序分为观察组及对照组各40例。对照组患者接受常规周剂量紫杉醇,观察组患者接受放射治疗同步周剂量紫杉醇,比较两组患者临床疗效、免疫功能等指标。结果:观察组有效率77.50%明显高于对照组55.00%(P<0.05);观察组后循环血中CD4~+T淋巴细胞、NK细胞水平高于对照组患者,CD8~+T淋巴细胞水平低于对照组患者(P<0.05)。结论:放射治疗同步周剂量紫杉醇有助于提高局部晚期非小细胞肺癌的近期疗效,可能与改善机体免疫能力有关。
Objective:to analyze radiation therapy synchronous weekly dose of taxol in the treatment of locally advanced non- small cell lung cancer.Methods:in May 2012- May 2014,80 cases of patients with locally advanced non- small cell lung cancer in the study object,according to the time sequence is divided into observation group and control group(n = 40).Control group patients received regular weekly dose paclitaxel,synchronous observation group of patients receiing radiation therapy for weeks dose of paclitaxel,comparing two groups of clinical curative effect,immune function and so on.Results:55.00%77.50%efficient observation group was obviously higher than that of control group(P < 0.05);In the observation group after the circulation of blood CD4 + T lymphocyte and NK cell levels higher than the control group patients,CD8 + T lymphocytes level is lower than the control group patients(P < 0.05).Conclusion:radiotherapy synchronous weeks dose of taxol is helpful to improve the recent efficacy of locally advanced non- small cell lung cancer,may be related to improving the bodys immune ability.
引文
[1]Eisenhauer EA,Therasse P,Boqaerts J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline(version 1.1)[J].Eur J Cancer,2009,45(2):228-47.
    [2]聂志勇.培美曲塞联合顺铂治疗老年晚期肺腺癌的疗效与安全性分析[J].中国实用医药,2016,11(15):166-168.
    [3]祝明池,王丽丽.斯普林联合放射治疗对局部晚期非小细胞肺癌免疫功能的影响[J].中国肿瘤临床与康复,2015,22(4):397-399.
    [4]彭雷,卢鑫,朱兆峰,等.调强放射治疗同步周剂量紫杉醇治疗局部晚期老年非小细胞肺癌的临床观察[J].中国肿瘤临床与康复,2013,20(12):1364-1366.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700